BelHealth Investment Partners has appointed Paul Barrett to its investment team as an associate. Barrett will be active in executing new transactions and working closely with existing portfolio companies.

Healthcare-focused buyout firm BelHealth Investment Partners has completed its acquisition of specialty pharmacy Town Total Health. BelHealth also announced that healthcare and specialty pharmacy executive Michael A. Nameth has joined Town Total as CEO.

BelHealth Investment Partners has raised $150 million with its latest fund, which is below its $200 million target. The fund is still more than twice what its prior pool collected, says Harold Blue, a managing partner.

Michael Brochu has joined the operating committee of BelHealth Investment Partners. Brochu was most recently the and CEO of Global Market Insite. PRESS RELEASE BelHealth Investment Partners, LLC (“BelHealth”) today announced that Michael Brochu has joined the Operating Committee. Mr. Brochu is a technology executive with over 20 years of senior-level experience at a variety of [...]

BelHealth Investment Partners said Tuesday that Dennis Drislane, chairman of the firm’s operating committee, is now full-time. The move follows the sale of TC³ Health, where he was Chairman and Chief Executive Officer. PRESS RELEASE BelHealth Investment Partners LLC (“BelHealth”) today announced that Dennis Drislane, Chairman of BelHealth’s operating committee, has moved from part-time to [...]

Joseph Wynne has joined BelHealth Investment Partners as chief financial and adminstrative officer. Previously, he was partner, CFO and registered financial principal of Commonwealth Associates amd ComVest Group. PRESS RELEASE BelHealth Investment Partners, LLC (“BelHealth”) today announced that Joseph P. Wynne, CPA, has joined the firm as its Chief Financial and Administrative Officer. Mr. Wynne [...]

SkilaMederi, a portfolio company of BelHealth Investment Partners, has appointed Kilian Weiss as CEO and Dr. Richard Nichol as chairman of the board.  Drew McCartney, SkilaMederi’s ex-CEO, will remain the board and focus on being an operating partner for BelHealth. SkilaMederi provides key opinion leader and launch management solutions using software and social network analytics [...]

Skila, which is backed by BelHealth Investment Partners, is merging wtih Mederi AG. Financial terms weren’t announced. Frankfurt, Germany-based Mederi provides pharmaceutical analytics and social network intelligence to life sciences companies. The new company will be called SkilaMederi. PRESS RELEASE Skila, a leading provider of fully managed “Solution as-a-Service” (SaaS) product launch and key opinion [...]

BelHealth Investment Partners plans to officially begin marketing for a new fund in September, sources say.

The pool, which will have a $200 million target, is the first for BelHealth, persons say. The PE firm held a $60 million first close in June, but those funds came internally from BelHealth executives.

In September, BelHealth plans to begin fundraising to outside investors, including institutions, a second person says. A second close is expected at the end of that month, the person says.

Fundraising is anticipated to end later this year but will likely extend into March. BelHealth has hired a placement agent in Europe but is currently on the hunt for one in the U.S., sources say.

Drew McCartney has joined BelHealth Investment Partners’ operating committee. Recently, McCartney served as the Executive-In-Residence at DW Healthcare Partners. Port Washington, N.Y.-based BelHealth is a PE firm focused on the small-cap healthcare industry.